Profund Advisors LLC Immuno Gen, Inc. Transaction History

Profund Advisors LLC

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2023 Feb 14, 2024	SELL	$12.46 - $29.95 $546,209 - $1.31 Million	-43,837 Reduced 44.66%	54,327 $1.61 Million
Q3 2023 Nov 13, 2023	BUY	$14.09 - $19.87 $471,296 - $664,631	33,449 Added 51.69%	98,164 $1.56 Million
Q2 2023 Aug 10, 2023	SELL	$3.75 - $20.05 $705,416 - $3.77 Million	-188,111 Reduced 74.4%	64,715 $1.22 Million
Q1 2023 May 11, 2023	BUY	$3.67 - $4.92 $927,871 - $1.24 Million	252,826 New	252,826 $970,000

1.41M

Ticker IMGN
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 220,712,992
Description
ImmunoGen, Inc., a clinical-stage biotechnology company, develops antibody-drug conjugate (ADC) therapies to treat cancer. The company's product candidates include mirvetuximab soravtansine, an ADC targeting folate-receptor alpha (FRa), which is in Phase III clinical trial for the treatment of platinum-resistant ovarian cancer; and Pivekimab sun...

Get notified when there are updates to the investment portfolio of Profund Advisors LLC, based on Form 13F filings with the SEC.

Stay updated on Profund Advisors LLC with notifications on news.